The International Peace Maternity & Child Health Hospital of China welfare institute Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2016
NCT02912104
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dongmei Lai | The International Peace Maternity & Child Health Hospital of China welfare institute

Active Ingredients

Drugs in Phase 1 Trials (1)

amniotic epithelial cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 1)

Menopause, Premature (Phase 1)

Primary Ovarian Insufficiency (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1